These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Neuroprotection for ischaemic stroke: current status and challenges. Moretti A; Ferrari F; Villa RF Pharmacol Ther; 2015 Feb; 146():23-34. PubMed ID: 25196155 [TBL] [Abstract][Full Text] [Related]
46. The only evidence based neuroprotective therapy for acute ischemic stroke: thrombolysis. Köhrmann M; Schellinger PD; Schwab S Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):563-71. PubMed ID: 21619867 [TBL] [Abstract][Full Text] [Related]
47. Translational medicine for stroke drug discovery: the pharmaceutical industry perspective. Feuerstein GZ; Chavez J Stroke; 2009 Mar; 40(3 Suppl):S121-5. PubMed ID: 19064772 [TBL] [Abstract][Full Text] [Related]
48. Pathophysiological basis of translational stroke research. Hossmann KA Folia Neuropathol; 2009; 47(3):213-27. PubMed ID: 19813140 [TBL] [Abstract][Full Text] [Related]
50. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Stenzel-Poore MP; Stevens SL; Xiong Z; Lessov NS; Harrington CA; Mori M; Meller R; Rosenzweig HL; Tobar E; Shaw TE; Chu X; Simon RP Lancet; 2003 Sep; 362(9389):1028-37. PubMed ID: 14522533 [TBL] [Abstract][Full Text] [Related]
51. Brain drain. Spotting a stroke fast can prevent damage. Berg EG Diabetes Forecast; 2013 Sep; 66(9):32-3. PubMed ID: 24156141 [No Abstract] [Full Text] [Related]
52. Lost in translation: taking neuroprotection from animal models to clinical trials. Hoyte L; Kaur J; Buchan AM Exp Neurol; 2004 Aug; 188(2):200-4. PubMed ID: 15246820 [TBL] [Abstract][Full Text] [Related]
53. Neuroprotection targeting ischemic penumbra and beyond for the treatment of ischemic stroke. Liu R; Yuan H; Yuan F; Yang SH Neurol Res; 2012 May; 34(4):331-7. PubMed ID: 22643076 [TBL] [Abstract][Full Text] [Related]
54. Nonhuman primate models of stroke for translational neuroprotection research. Cook DJ; Tymianski M Neurotherapeutics; 2012 Apr; 9(2):371-9. PubMed ID: 22437447 [TBL] [Abstract][Full Text] [Related]
55. Neuroprotection: establishing proof of concept in human stroke. Davis SM; Donnan GA Stroke; 2002 Jan; 33(1):309-10. PubMed ID: 11779931 [No Abstract] [Full Text] [Related]
57. Fast neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now. Lapchak PA Transl Stroke Res; 2013 Dec; 4(6):704-9. PubMed ID: 24323424 [No Abstract] [Full Text] [Related]
58. Neuroprotection is unlikely to be effective in humans using current trial designs: an opposing view. Lees KR Stroke; 2002 Jan; 33(1):308-9. PubMed ID: 11779930 [No Abstract] [Full Text] [Related]